Scientists have identified a simple, inexpensive compound that made cancer drugs more effective in mice and helped human patients weather the toxic side effects of chemotherapy. But even as they touted their experimental results, they acknowledged that their remedy was unlikely to inspire the vigorous — and expensive — research necessary to win regulatory approval and join the ranks of mainstream medicine.